Highlights
- 1
Publications
37 publications
Funding
8 grants
Active
7 grants- Co-IR01CA317908-01Systemic Theranostic 203Pb/212Pb Alpha-Radioimmunotherapy for Advanced Colorectal CancerNational Cancer Institute · 2026–2031
- Co-IR01NS135205-01A1Quantitative cerebral oxygen metabolic imaging of acute ischemic strokeNational Institute of Neurological Disorders and Stroke · 2024–2029
- Co-IHT9425-25-1-0152Theranostic Trop-2-directed pretargeted radioimmunotherapy for metastatic prostate cancer with curative intentU.S. Department of Defense · 2025–2028
- KPC06OD036045-01Modernization and Expansion of the Citigroup Biomedical Imaging Center at Weill Cornell Medical CollegeOffice of the Director, NIH · 2023–2027
- Co-IR21CA287211-01A1An engineered bacterial reporter gene fusion for radiotheranosticsNational Cancer Institute · 2024–2027
- Co-I24CHAL11Development and optimization of CEACAM5-targeted alpha emittersProstate Cancer Foundation · 2025–2027
- KPS10OD034271-01New PET/CT System for Human and Non-human Primate ImagingOffice of the Director, NIH · 2023–2026
Completed grants (1)
- Co-IR01CA233896-05DOTA-based pre-targeting of alpha emittersNational Cancer Institute · 2018–2024· 2 renewals